SPTM vs. ITOT: Which Total U.S. Stock Market ETF Is the Better Buy in 2026?

ITOT and SPTM are presented as near-identical low-cost U.S. total market ETFs, each charging a 0.03% expense ratio and offering broad equity exposure with about 37% in technology. ITOT has slightly wider market breadth and a larger AUM base of $93.4 billion versus $13.6 billion for SPTM, while SPTM showed a modest 5-year performance edge ($1,819 vs. $1,756 growth of $1,000). The piece is mainly comparative and informational, with no material catalyst expected for the broader market.

Analysis

The real signal here is not that these are interchangeable core ETFs; it’s that the U.S. market remains highly concentrated at the index level, so “broad market” exposure is functionally a levered bet on a small set of mega-cap software/AI beneficiaries. With NVDA, AAPL, and MSFT doing most of the heavy lifting, these vehicles inherit the same factor loadings as a concentrated growth basket while still advertising diversification. That makes them less useful as true ballast in a portfolio than many allocators assume, especially if the next leg in megacap tech is driven by multiple compression rather than earnings acceleration.

The second-order effect is on capital flows: if advisors continue defaulting to total-market products as the core holding, incremental marginal demand will keep flowing into the same top names regardless of fundamentals, reinforcing passive support and dampening near-term drawdowns. That creates a feedback loop where the “broad market” can stay elevated even as breadth deteriorates underneath; the opportunity is to fade the illusion of diversification by expressing relative value against equal-weight, small-cap, or quality-factor exposures that are less dependent on the AI complex.

The more interesting contrarian point is that the slight breadth advantage of the more complete total-market fund may matter only if small caps stop being a valuation trap and start participating in earnings revisions. If rates drift lower over the next 6-12 months, the under-owned lower-cap segment could outperform on financing relief and domestic cyclicality, while the mega-cap leaders become more sensitive to any growth scare. In that scenario, the current consensus view that these ETFs are equally defensive is wrong: the broader one has slightly more optionality if market leadership rotates away from the very top names.

Key Decisions for Investors

• Prefer a relative-value long ITOT / short QQQ pair over the next 3-6 months: captures market participation while reducing single-factor concentration risk; best if breadth improves or AI multiples compress.
• Fade passive mega-cap concentration via a basket short in NVDA/AAPL/MSFT against a long in ITOT on a 1-2 quarter horizon; thesis is that index-driven flows are already crowded and upside is increasingly dependent on continued multiple expansion.
• If the desk needs core U.S. beta, use ITOT instead of SPTM and pair it with a small-cap overweight (IWM or IJR) to monetize any 6-12 month rate-cut rotation; stop if small-cap relative strength fails to confirm by quarter-end.
• For investors already long large-cap growth, add a downside hedge with QQQ put spreads 3-6 months out; risk/reward improves if breadth weakens before earnings revisions roll over.